Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Compared to the CON diet, the ALM diet increased the post-intervention value of plasma α-tocopherol by 10.2 % (P = 0.0065) and decreased γ-tocopherol by 16.5 % (P = 0.047).The change in nutrient consumption before the run-in and at the end of the 2 interventionsaBefore run-inAlmond dietControl dietCalories, Kcal1732.9 ± 859.12049.8 ± 733.0bd1579.6 ± 784.8cProteins, g70.5 ± 32.386.6 ± 33.1bd67.1 ± 28.4cAnimal protein, g44.3 ± 21.745.4 ± 24.843.9 ± 19.4Protein, % Kcal16.8 ± 3.616.9 ± 2.617.6 ± 3.3Carbohydrates, g232.0 ± 28.7215.4 ± 101.1215.3 ± 122.8Carbohydrate, % Kcal53.4 ± 7.340.7 ± 7.8bd53.2 ± 8.3cTotal Fats, g59.9 ± 37.398.1 ± 30.8b50.6 ± 27.9cFat % Kcal30.5 ± 6.044.4 ± 7.2bd29.1 ± 6.8cSFA, g19.7 ± 13.220.3 ± 10.1b16.4 ± 9.4cdSFA % Kcal9.9 ± 2.88.8 ± 2.2d9.4 ± 2.8MUFA, g21.6 ± 13.348.1 ± 12.0bd18.3 ± 10.3cdMUFA % Kcal11.2 ± 2.522.4 ± 4.9bd10.6 ± 3.0cPUFA, g12.9 ± 8.322.5 ± 7.0bd11.0 ± 6.7cPUFA % Kcal6.6 ± 1.710.2 ± 1.6bd6.3 ± 1.5cCholesterols, mg201.8 ± 148.6197.8 ± 133.3188.2 ± 94.3Fiber, g19.7 ± 11.228.7 ± 10.0bd18.7 ± 12.5cGlucose, g22.3 ± 15.318.5 ± 11.819.6 ± 13.9Sucrose, g42.6 ± 29.037.1 ± 24.439.1 ± 31.2Fructose, g23.6 ± 17.419.9 ± 13.521.5 ± 16.8Alcohol, g2.3 ± 3.73.1 ± 4.33.3 ± 4.9Caffeine, mg152.7 152.5128.2 ± 117.0133.7 ± 139.8Vitamins Vitamin A, IU10759.2 ± 6077.710612.5 ± 7059.110880.6 ± 7530.9 Vitamin C, mg163.6 ± 183.5117.7 ± 105.1129.9 ± 108.3 Vitamin D, IU405.9 ± 339.6381.2 ± 372.2397.3 ± 372.9 a-Tocopherol, mg7.0 ± 3.734.5 ± 9.8bd17.0 ± 29.4cd Vitamin K, μg143.1 ± 102.7135.9 ± 85.5150.2 ± 125.0 Vitamin B1, mg3.3 ± 7.73.2 ± 7.73.1 ± 7.6 Vitamin B2, mg4.0 ± 7.84.6 ± 7.8b3.7 ± 7.7c Niacin, mg37.1 ± 40.237.1 ± 38.934.9 ± 38.9 Vitamin B6, mg4.6 ± 8.65.7 ± 11.46.7 ± 17.1 Folate, μg943.9 ± 568.3567.4 ± 346.7d580.1 ± 378.3d Vitamin B12, μg46.3 ± 127.857.8 ± 145.267.1 ± 161.2 Choline, mg288.5 ± 140.4325.7 ± 142.6b274.2 ± 116.6c Pantothenic acid, mg10.6 ± 10.39.6 ± 10.39.7 ± 10.2 Retinol, IU2767.5 ± 1785.92388.0 ± 2813.22412.3 ± 1965.0Phytochemicals Flavonoids, mg252.2 ± 317.0205.4 ± 252.7204.7 ± 243.0 Proanthocyanins, mg127.5 ± 90.9275.2 ± 87.5bd117.3 ± 114.8c Carotenoids, mg7991.7 ± 5219.58222.5 ± 5679.88459.3 ± 6667.4Minerals Calcium, mg982.1 ± 651.31078.5 ± 594.5b865.5 ± 490.0c Copper, mg2.0 ± 1.32.8 ± 1.8bd1.9 ± 1.5c Iodine, μg37.1 ± 63.537.1 ± 63.540.5 ± 72.8 Iron, mg17.0 ± 11.319.0 ± 11.919.0 ± 16.0 Potassium, mg2861.9 ± 1334.93261.2 ± 1329.2b2697.2 ± 1312.5c Magnesium, mg345.2 ± 190.5544.5 ± 167.9bd319.9 ± 174.8c Manganese, mg4.1 ± 2.45.6 ± 2.4bd4.0 ± 2.5c Phosphate, mg1234.0 ± 571.21537.5 ± 553.7bd1144.2 ± 522.7c Selenium, μg5.0 ± 8.512.2 ± 22.410.3 ± 25.4 Zinc, mg14.4 ± 8.916.9 ± 9.6bd14.5 ± 11.2cAmino acids Alanine, g3.3 ± 1.64.2 ± 1.6bd3.2 ± 1.3c Arginine, g3.9 ± 1.96.0 ± 1.8bd3.7 ± 1.5b Aspartic acid, g6.5 ± 3.08.6 ± 3.0bd6.1 ± 2.6c Cysteine, g1.1 ± 0.51.2 ± 0.5b1.0 ± 0.5c Glutamic acid, g13.7 ± 6.318.3 ± 6.3bd12.9 ± 5.7c Glycine, g3.0 ± 1.44.2 ± 1.4bd2.8 ± 1.2c Histidine, g1.9 ± 0.92.4 ± 0.9bc1.8 ± 0.8c Isoleucine, g3.2 ± 1.53.7 ± 1.5b3.0 ± 1.3c Leucine, g5.6 ± 2.66.7 ± 2.7b5.3 ± 2.2c Lysine, g4.7 ± 2.25.2 ± 2.44.6 ± 1.9 Methionine, g1.6 ± 0.71.7 ± 0.8b1.5 ± 0.6c Phenylalanine, g3.2 ± 1.44.0 ± 1.5bd3.0 ± 1.3c Proline, g4.6 ± 2.25.0 ± 2.2b4.2 ± 2.0c Serine, g3.3 ± 1.53.9 ± 1.5b3.1 ± 1.3c Threonine, g2.6 ± 1.23.1 ± 1.2b2.5 ± 1.0 Tryptophan, g0.8 ± 0.30.9 ± 0.3b0.7 ± 0.3c Tyrosine, g2.4 ± 1.12.7 ± 1.2b2.3 ± 1.0c Valine, g3.7 ± 1.74.3 ± 1.7b3.5 ± 1.5caAbbreviation: CHO carbohydrates, SFA saturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsaturated fatty acidsbcMeans with different letters between almond and control diets differ, tested by LSMEANSdMeans differ from those of before the run-in, tested by Student’s t-test
Source: Nutrient intake and status. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Randomised controlled trial.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
A randomized, controlled, crossover trial was conducted in Boston, MA to test whether as compared to a control NCEP Step 1 diet absent nuts (CON), incorporation of almonds (85 g/day) into the CON diet (ALM) would improve vascular function and inflammation.
Source: Abstract.
Drug therapies used by patients were stable throughout the duration of the trial.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial
Randomised controlled trial · Nutrition Journal · 2015
Original publication title
Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial
© Chen et al. 2015
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Almonds reduce cardiovascular disease risk via cholesterol reduction, anti-inflammation, glucoregulation, and antioxidation. The objective of this randomized, controlled, cross-over trial was to determine whether the addition of 85 g almonds daily to a National Cholesterol Education Program (NCEP) Step 1 diet (ALM) for 6 weeks would improve vascular function and inflammation in patients with coronary artery disease (CAD).
Source: ObjectiveAbstract: Research design and methods
A randomized, controlled, crossover trial was conducted in Boston, MA to test whether as compared to a control NCEP Step 1 diet absent nuts (CON), incorporation of almonds (85 g/day) into the CON diet (ALM) would improve vascular function and inflammation. The study duration was 22 weeks including a 6-weeks run-in period, two 6-weeks intervention phases, and a 4-weeks washout period between the intervention phases. A total of 45 CAD patients (27 F/18 M, 45 to 77 y, BMI = 20-41 kg/m2) completed the study.
Drug therapies used by patients were stable throughout the duration of the trial.
Source: Research design and methodsAbstract: Results
The addition of almonds to the CON diet increased plasma α-tocopherol status by a mean of 5.8 %, reflecting patient compliance (P ≤0.05). However, the ALM diet did not alter vascular function assessed by measures of flow-mediated dilation, peripheral arterial tonometry, and pulse wave velocity. Further, the ALM diet did not significantly modify the serum lipid profile, blood pressure, C-reactive protein, tumor necrosis factor-α or E-selectin. The ALM diet tended to decrease vascular cell adhesion molecule-1 by 5.3 % (P = 0.064) and increase urinary nitric oxide by 17.5 % (P = 0.112).
The ALM intervention improved the overall quality of the diet by increasing calcium, magnesium, choline, and fiber intakes above the Estimated Average Requirement (EAR) or Recommended Dietary Allowance (RDA).
Source: ResultsAbstract: Conclusions
Thus, the addition of almonds to a NECP Step 1 diet did not significantly impact vascular function, lipid profile or systematic inflammation in CAD patients receiving good medical care and polypharmacy therapies but did improve diet quality without any untoward effect.
Source: ConclusionsAuthors’ abstract
Objective
Almonds reduce cardiovascular disease risk via cholesterol reduction, anti-inflammation, glucoregulation, and antioxidation. The objective of this randomized, controlled, cross-over trial was to determine whether the addition of 85 g almonds daily to a National Cholesterol Education Program (NCEP) Step 1 diet (ALM) for 6 weeks would improve vascular function and inflammation in patients with coronary artery disease (CAD).
Research design and methods
A randomized, controlled, crossover trial was conducted in Boston, MA to test whether as compared to a control NCEP Step 1 diet absent nuts (CON), incorporation of almonds (85 g/day) into the CON diet (ALM) would improve vascular function and inflammation. The study duration was 22 weeks including a 6-weeks run-in period, two 6-weeks intervention phases, and a 4-weeks washout period between the intervention phases. A total of 45 CAD patients (27 F/18 M, 45 to 77 y, BMI = 20-41 kg/m2) completed the study.
Drug therapies used by patients were stable throughout the duration of the trial.
Results
The addition of almonds to the CON diet increased plasma α-tocopherol status by a mean of 5.8 %, reflecting patient compliance (P ≤0.05). However, the ALM diet did not alter vascular function assessed by measures of flow-mediated dilation, peripheral arterial tonometry, and pulse wave velocity. Further, the ALM diet did not significantly modify the serum lipid profile, blood pressure, C-reactive protein, tumor necrosis factor-α or E-selectin. The ALM diet tended to decrease vascular cell adhesion molecule-1 by 5.3 % (P = 0.064) and increase urinary nitric oxide by 17.5 % (P = 0.112).
The ALM intervention improved the overall quality of the diet by increasing calcium, magnesium, choline, and fiber intakes above the Estimated Average Requirement (EAR) or Recommended Dietary Allowance (RDA).
Conclusions
Thus, the addition of almonds to a NECP Step 1 diet did not significantly impact vascular function, lipid profile or systematic inflammation in CAD patients receiving good medical care and polypharmacy therapies but did improve diet quality without any untoward effect.
Trial registration
The trial was registered with the ClinicalTrials.Gov with the identifier: NCT00782015.
Publication and source details
Original title: Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial
C-Y. Oliver Chen; Monika Holbrook; Mai-Ann Duess; Mustali M Dohadwala; Naomi M Hamburg; Bela F. Asztalos; Paul E. Milbury; Jeffrey B. Blumberg; Joseph A. Vita
Nutrition Journal · 2015
© Chen et al. 2015https://creativecommons.org/licenses/by/4.0/This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T20:28:21.365671+00:00
DOI: 10.1186/s12937-015-0049-5 · PMC4469426